Cargando…

KRAS mutation in relation to HER2 overexpression/amplification in colorectal cancer

Detalles Bibliográficos
Autores principales:	Bar, Julia K, Lis-Nawara, Anna, Lebioda, Arleta, Jonkisz, Anna, Jeleń, Michał, Dobosz, Tadeusz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3518233/ http://dx.doi.org/10.1186/1897-4287-10-S4-A25

Ejemplares similares

Serotonin-Related Gene Variants in Patients with Irritable Bowel Syndrome and Depressive or Anxiety Disorders
por: Grzesiak, Magdalena, et al.
Publicado: (2017)

The status of Her2 amplification and Kras mutations in mucinous ovarian carcinoma
por: Chang, Kuang-Leei, et al.
Publicado: (2016)

Cardiac arrest during percutaneous coronary intervention in a patient ‘resistant’ to clopidogrel – successful 50-minute mechanical chest compression
por: Protasiewicz, Marcin, et al.
Publicado: (2013)

KRAS gene amplification and overexpression but not mutation associates with aggressive and metastatic endometrial cancer
por: Birkeland, E, et al.
Publicado: (2012)

The influence of acute coronary syndrome on levels of clopidogrel active metabolite and platelet inhibition in patients with and without CYP2C19*2(681 G>A), *3(636 G>A) and ABCB1(C3435C> T) gene polymorphisms
por: Wójcik, Tomasz, et al.
Publicado: (2021)

Dental Pulp Stem Cell-Derived Secretome and Its Regenerative Potential
por: Bar, Julia K., et al.
Publicado: (2021)

A phase I trial of the pan-ERBB inhibitor neratinib combined with the MEK inhibitor trametinib in patients with advanced cancer with EGFR mutation/amplification, HER2 mutation/amplification, HER3/4 mutation or KRAS mutation
por: Piha-Paul, Sarina A., et al.
Publicado: (2023)

Haplotype-defined linkage region for gPRA in Schapendoes dogs
por: Lippmann, Tanja, et al.
Publicado: (2007)

Utility of direct 3D co-culture model for chondrogenic differentiation of mesenchymal stem cells on hyaluronan scaffold (Hyaff-11)
por: Deszcz, Iwona, et al.
Publicado: (2020)

The hero of American and Polish nations: a molecular look at Thaddeus Kosciuszko’s cause of death suggests a contribution of endocarditis caused by Cutibacterium acnes infection
por: Witt, Michał, et al.
Publicado: (2022)

Somatic mutation profiling and HER2 status in KRAS-positive Chinese colorectal cancer patients
por: Dong, Zhouhuan, et al.
Publicado: (2019)

Competitive amplification of differentially melting amplicons (CADMA) improves KRAS hotspot mutation testing in colorectal cancer
por: Kristensen, Lasse Sommer, et al.
Publicado: (2012)

Identification and In Silico Characterization of a Novel COLGALT2 Gene Variant in a Child with Mucosal Rectal Prolapse
por: Sadakierska-Chudy, Anna, et al.
Publicado: (2022)

KRAS mutation analysis in ductal carcinoma of the pancreas; prognostic implications in elderly patients
por: Oldani, Alberto, et al.
Publicado: (2013)

Comparison of tumors with HER2 overexpression versus HER2 amplification in HER2-positive breast cancer patients
por: Horimoto, Yoshiya, et al.
Publicado: (2022)

Identification of KRAS mutation and HER2 expression in Indonesian colorectal cancer population: a cross-sectional study
por: Rudiman, Reno, et al.
Publicado: (2023)

Prognostic Value of KRAS Mutations in Colorectal Cancer Patients
por: Koulouridi, Asimina, et al.
Publicado: (2022)

Somatic mutation detection and KRAS amplification in testicular germ cell tumors
por: Cabral, Eduardo R. M., et al.
Publicado: (2023)

Low frequency of HER2 amplification and overexpression in early onset gastric cancer
por: Moelans, Cathy B., et al.
Publicado: (2011)

Restitution of valuable characters of the declining polish sheep bred "wrzosowka" with regard to fecundity and coat utility
por: Nawara, W
Publicado: (1977)

Comparison of p53, HSP90, E-cadherin and HPV in oral lichen planus and oral squamous cell carcinoma
por: Bar, Julia K., et al.
Publicado: (2021)

Targeting HER2 in colorectal cancer: The landscape of amplification and short variant mutations in ERBB2 and ERBB3
por: Ross, Jeffrey S., et al.
Publicado: (2018)

Significance of HER2 protein expression and HER2 gene amplification in colorectal adenocarcinomas
por: Wang, Xin-Yu, et al.
Publicado: (2019)

Influence of lactose intolerance on colorectal cancer incidence in the Polish population
por: Andrzej, Plawski, et al.
Publicado: (2015)

KRAS and TP53 Mutations in Colorectal Carcinoma
por: Al-Kuraya, Khawla S.
Publicado: (2009)

Impact of KRAS Mutations on Management of Colorectal Carcinoma
por: Sullivan, Kevin M., et al.
Publicado: (2011)

KRAS mutations in patients with colorectal cancer in Libya
por: Abudabous, Asma, et al.
Publicado: (2021)

The Therapeutic Landscape for KRAS-Mutated Colorectal Cancers
por: Tria, Simon Manuel, et al.
Publicado: (2023)

Detection of KRAS mutant alleles in circulating cell-free tumor DNA in colorectal cancer patients resistant to cetuximab
por: Del Re, Marzia, et al.
Publicado: (2014)

Characterization of Biological Properties of Dental Pulp Stem Cells Grown on an Electrospun Poly(l-lactide-co-caprolactone) Scaffold
por: Bar, Julia K., et al.
Publicado: (2022)

TOPOIIα and HER-2/neu overexpression/amplification in Barrett’s oesophagus, dysplasia and adenocarcinoma
por: Rossi, Elisa, et al.
Publicado: (2010)

HER2 Protein Overexpression and Gene Amplification in Plasmacytoid Urothelial Carcinoma of the Urinary Bladder
por: Kim, Bohyun, et al.
Publicado: (2016)

Zuchtprogramm und zielgesetztes selektionverfahren bei schafzucht in polen
por: Nawara, W, et al.
Publicado: (1980)

Zuchtprogramm und zielgesetztes selektionverfahren bei schafzucht in polen
por: Nawara, W, et al.
Publicado: (1980)

Her2 assessment using quantitative reverse transcriptase polymerase chain reaction reliably identifies Her2 overexpression without amplification in breast cancer cases
por: Zoppoli, Gabriele, et al.
Publicado: (2017)

HER2 Amplification in p53-Mutated Endometrial Carcinomas
por: Balestra, Ambre, et al.
Publicado: (2023)

KRAS, NRAS, BRAF, HER2 and MSI Status in a Large Consecutive Series of Colorectal Carcinomas
por: Martianov, Aleksandr S., et al.
Publicado: (2023)

HER2 overexpression and amplification as a potential therapeutic target in colorectal cancer: analysis of 3256 patients enrolled in the QUASAR, FOCUS and PICCOLO colorectal cancer trials
por: Richman, Susan D, et al.
Publicado: (2016)

Molecular landscape of TP53 mutations in breast cancer and their utility for predicting the response to HER‐targeted therapy in HER2 amplification‐positive and HER2 mutation‐positive amplification‐negative patients
por: Liu, Binliang, et al.
Publicado: (2022)

HER2 overexpression and amplification is present in a subset of ovarian mucinous carcinomas and can be targeted with trastuzumab therapy
por: McAlpine, Jessica N, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_6kd7atnhd3muoidessfdk8jl6o